Differences in physician and patient perceptions about insulin therapy for management of type 2 diabetes: the DAWN Japan study

Current Medical Research and Opinion

Volumn 30, Issue 2, 2014, Pages 177-183

  Yoshioka, Narihito ^a   Ishii, Hitoshi ^b   Tajima, Naoko ^c   Iwamoto, Yasuhiko ^d  

^a Sapporo Medical Center   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Insulin; Patient's perception; Physician's perception; Psychological insulin resistance; Type 2 diabetes

Indexed keywords

INSULIN;

ADULT; ARTICLE; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTION; PHYSICIAN; PHYSICIAN ATTITUDE; PSYCHOLOGICAL INSULIN RESISTANCE; QUESTIONNAIRE; ATTITUDE TO HEALTH; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; HEALTH PERSONNEL ATTITUDE; JAPAN; MULTICENTER STUDY; PATIENT; PATIENT EDUCATION; PSYCHOLOGY;

ADULT; ATTITUDE OF HEALTH PERSONNEL; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INSULIN; JAPAN; MALE; MIDDLE AGED; PATIENT MEDICATION KNOWLEDGE; PATIENTS; PERCEPTION; PHYSICIANS; QUESTIONNAIRES;

EID: 84893330227     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.855187     Document Type: Article

References (23)

1. Maedler K, Donath MY. Beta-cells in type 2 diabetes: A loss of function and mass. Horm Res 2004;62:67-73
2. Wright A, Burden AC, Paisey RB, et al. Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6
3. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89
4. U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-36
5. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients fears and hopes about insulin therapy. Diabetes Care 1997;20:292-8
6. Ratzmann K. The psychological aspects of diabetes with the secondary failure of sulfonylurea therapy. Dtsch Med Wochenschr 1991;116:87-90
7. Polonsky WH, Richard AJ. Whats so tough about taking insulin? Addressing the problem of psychological insulin resistance in Type 2 Diabetes. Clin Diabetes 2004;22:147-50
8. Polonsky WH, Fisher L, Guzman S, et al. psychological insulin resistance in patients with Type 2 Diabetes the scope of the problem. Diabetes Care 2005;28:2543-5
9. Brod M, Kongsø JH, Lessard S, et al. Psychological insulin resistance: Patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
10. Funnell MM. Overcoming barriers to the initiation of insulin therapy. Clin Diabetes 2007;25:36-8
11. Peyrot M, Rubin RR, Lauritzen T, et al. The International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9
12. Ishii H, Iwamoto Y, Tajima N. An exploration of barriers to insulin initiation for physicians in Japan: Findings from the Diabetes Attitudes, Wishes and Needs (DAWN) JAPAN Study. PLoS One 2012;7:e36361
13. World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Last amended by the 59th WMA General Assembly, Seoul, Korea. 2008
14. Ministry of Education, Culture, Sports, Science & Technology and the Ministry of Health, Labor & Welfare. Ethical guidelines for epidemiological research. Tokyo: Ministry of Education, Culture, Sports, Science & Technology and the Ministry of Health, Labor & Welfare, 2002
15. Wulff H. The two cultures of medicine: Objective facts versus subjectivity and values. J R Soc Med 1999;92:549-52
16. Nakar S, Yitzhaki G, Rosenberg R, et al. Transition to insulin in type 2 diabetes: Family physicians misconceptions of patients fears contributes to existing barriers. J Diabetes Compl 2007;21:220-6
17. Haque M, Emerson SH, Dennison CR, et al. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J 2005;95:798-802
18. Jeavons D, Hungin APS, Cornford CS. Patients with poorly controlled diabetes in primary care: Healthcare clinicians beliefs and attitudes. Postgrad Med J 2006;82:347-50
19. Leslie CA, Satin-Rapaport W. Psychological insulin resistance-A challenge for diabetes patients and health professionals. Todays Therapeut Trend 1995;13:21-7
20. Rubin RR, Peyrot M. Psychological issues and treatments in people with diabetes. J Clin Psychol 2001;57:457-8
21. Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ 2004;30:274-80
22. Snoek J. Breaking the barriers to optimal glycaemic control-what physicians need to know from patients perspectives. Int J Clin Pract Suppl 2002;129:80-4
23. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ 2006;32:9S-18S